Elizabeth R. Kirk, Director of the Center for Law & the Human Person at Catholic Law, recently contributed an article to Our Sunday Visitor. Published on May 1, 2023, Kirk’s featured article “Buyer beware: Women’s safety is a key oversight in the abortion pill debate” discussed the nature of legal claims made about the health risks of mifepristone, the birth control drug at the center of litigation in lower courts throughout the country.
Our Sunday Visitor
Date: May 1, 2023
By: Elizabeth Kirk
Buyer beware: Women’s safety is a key oversight in the abortion pill debate
. . .
In late April, in the pending litigation regarding the U.S. Food and Drug Administration’s approval of mifepristone, the Supreme Court issued a procedural ruling to preserve access to the abortion drug, for now. No conclusions should be drawn about the merits of the case itself, as the Supreme Court did not rule on those. And as the litigation proceeds in the lower courts, all Americans, whatever their views on abortion, should hope that our adversarial system will accomplish its purpose: to resolve disputes in the search for truth.
. . .
Click here to view the article.